In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Spongiotic dermatitis describes skin inflammation that causes swelling, redness, and itching. It's most often associated with ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

When somebody's coming in that has a known diagnosis of atopic dermatitis or eczema and things are really revved up still, if ...

NKTR stock is up around 150% in today’s trading session following the recently announced positive results from its Phase 2b ...

Despite Nektar’s share price shooting up as much as 175% on Tuesday, William Blair maintained that “there is an absence of ...

Nektar Therapeutics (NASDAQ: NKTR) stock exploded nearly 157% following news that Rezpeg, the company’s experimental ...

The Food and Drug Administration in February granted fast track designation for rezpegaldesleukin to treat adults and pediatric patients 12 years and up with moderate to severe atopic dermatitis, the ...

According to a recent meta-analysis published in eClinicalMedicine, antibiotic use during pregnancy or in early childhood ...

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a ...